ECN Launches Phase 2 Neurology Study Across 8 Sites – ECN Demo Web

ECN Launches Phase 2 Neurology Study Across 8 Sites

Share:

New anti-amyloid therapy study opens enrollment at ECN Boston, Seattle, and six additional network sites.

Related News

From research breakthroughs to company updates, stay connected with the latest news and insights from across the Elite Clinical Network.

PI Spotlights

August 13, 2026

Elite Clinical Network and HealthyU Clinics Announce Strategic Partnership to Expand Access to Clinical Research

ECN's San Antonio site reaches 100% enrollment target six weeks ahead of schedule on Phase 3 SGLT2 inhibitor study.

Company News

August 14, 2026

ECN Expands Network to 25 Sites Across 18 States

Strategic growth continues with three new embedded research sites joining the ECN network in the Southeast corridor.

Conferences

August 14, 2026

ECN at DIA 2026: Advancing the Hybrid Site Model

ECN leadership presented enrollment predictability data showing 93% target attainment across active studies.